How to buy ADMA Biologics shares

ADMA Biologics Inc (ADMA) is a publicly traded biotechnology business based in the US. It opened the day at $1.45 after a previous close of $1.43. During the day the price has varied from a low of $1.4332 to a high of $1.5. The latest price was $1.5 (25 minute delay). ADMA Biologics is listed on the NASDAQ and employs 617 staff. All prices are listed in US Dollars.

Our top picks for where to buy ADMA Biologics shares:

Best for

0% commission

Best for

Beginner investments

Best for

Beginners

BEST FOR

US shares

Fees for buying 200x ADMA Biologics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform	Customer feedback	Monthly fee	Min. initial deposit	Trading fee estimate
	★★★★★	£0	$50	£1.23 £247.11 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£1.45 £247.33 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£9.47 £255.35 total	Go to site Capital at risk
	Not yet rated	£0	No minimum	£1.23 £247.11 total	Go to site Capital at risk
	★★★★★	£0	No minimum	£1.23 £247.11 total	Go to site Capital at risk
	★★★★★	£0	£1	£14.41 £260.29 total	Go to site Capital at risk

Full comparison of share dealing platforms

Alternative ways to invest in ADMA Biologics

• Invest in ADMA Biologics via a fund

  Buying shares in just one company can leave you more exposed to unexpected swings in the market than if you have a range of investments - a "diversified portfolio". Experts generally recommend having a broad mix of assets and funds that hold a ready-made portfolio of at least 50 different companies' shares, on the basis that drops in the value of some will be offset by rises elsewhere.

  ADMA Biologics is a major part of the NASDAQ index, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

Is it a good time to buy ADMA Biologics stock?

Only you can make the decision on the time to leap. The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

• See the technical analysis gauge

• See ADMA Biologics share price (NASDAQ:ADMA)

  Use our graph to track the performance of ADMA stocks over time.

  Share price volatility

  Over the last 12 months, ADMA Biologics's shares have ranged in value from as little as $2.24 up to $4.65. A popular way to gauge a stock's volatility is its "beta".

  Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ADMA Biologics's is 0.806. This would suggest that ADMA Biologics's shares are less volatile than average (for this exchange).

• What's ADMA Biologics price performance over time?

  Historical closes compared with the last close of $1.5

  1 week (2023-09-21)	-57.87%
  1 month (2023-09-01)	-61.44%
  3 months (2023-06-30)	-59.35%
  6 months (2023-03-31)	-54.68%
  1 year (2022-09-30)	-38.27%
  2 years (2021-09-27)	21.95%
  3 years (2020-10-01)	-32.74%
  5 years (2018-10-01)	-74.36%

Invest in ADMA Biologics shares

Finder Award

• Start investing from $50
• Pay no stamp duty on UK shares
• Commission-free trading. Other fees may apply.

Go to site

Capital at risk

Frequently asked questions

• Does ADMA Biologics pay dividends?

  We're not expecting ADMA Biologics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

  Currently 2.496% of ADMA Biologics shares are held by insiders and 77.719% by institutions.

• How many people work for ADMA Biologics?

  Latest data suggests 617 work at ADMA Biologics.

• When does the fiscal year end for ADMA Biologics?

  ADMA Biologics's fiscal year ends in December.

• Where is ADMA Biologics based?

  ADMA Biologics's address is: 465 State Route 17, Ramsey, NJ, United States, 07446

• What is ADMA Biologics's ISIN number?

  ADMA Biologics's international securities identification number is: US0008991046

• What is ADMA Biologics's CUSIP number?

  ADMA Biologics's Committee on Uniform Securities Identification Procedures number is: 000899104

• How to sell ADMA Biologics shares

  It's as easy to sell ADMA Biologics as it is to buy! Here's how to sell ADMA Biologics that you already own.

  1. Open your investment app. If you've got one with desktop access, you can log in online
  2. Go to your portfolio. This should be in the main menu
  3. Find your shares. You may be able to search your portfolio
  4. Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
  5. Sell your ADMA Biologics shares. Your investment platform will let you know when your shares are sold

• Can you buy ADMA Biologics shares with a debit card?

  Most share dealing providers in the UK will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.

• What's the easiest way to buy ADMA Biologics shares?

  The easiest way to get hold of some ADMA Biologics shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in ADMA Biologics shares.

• Do you need to complete a W8-BEN form if you want to invest in ADMA Biologics

  If you're investing in a US stock, you'll need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.

• What is the key financial information for ADMA Biologics?

  Financials

  Revenue TTM	$208.1 million
  Gross profit TTM	$35.3 million
  Return on assets TTM	-2.71%
  Return on equity TTM	-30.86%
  Profit margin	-19.36%
  Book value	$0.654
  Market capitalisation	$789.4 million

  TTM: trailing 12 months